This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letters  • Similar articles in JAMA  Topic Collections  • Medical Practice  • Medical Ethics  • Cardiovascular System  • Quality of Care  • Patient Safety/ Medical Error  • Statistics and Research Methods  • Cardiovascular Disease/ Myocardial Infarction  • Hematology/ Hematologic Malignancies  • Anemias  • Hematology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Dr Levien and colleagues and Dr Keipert and colleagues suggest that our meta-analysis should have included additional studies.^1-2 The first article is not indexed in PubMed, EMBASE, or the Cochrane Library; moreover, it is not a controlled study, the major criterion for inclusion in our meta-analysis. Regarding the second study, as shown in the PubMed record, it was not fully coded with MeSH terms until July 2, 2008, and therefore could not have shown up on the March 25 term-based PubMed search. The study was present in EMBASE on July 2, 2008, but evidently was not present on March 25, 2008; we cannot determine when it was entered. The study was still not present in the Cochrane Library as of July 2, 2008. Regardless, the study had no fatalities or MIs in either study arm and therefore would have had no impact on our reported relative risks.

Keipert . . . [Full Text of this Article]

Charles Natanson, MD
cnatanson@cc.nih.gov
Critical Care Medicine Department
Clinical Center
National Institutes of Health
Bethesda, Maryland

Peter Lurie, MD, MPH; Sidney M. Wolfe, MD
Health Research Group
Public Citizen
Washington, DC

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death: A Meta-analysis
Charles Natanson, Steven J. Kern, Peter Lurie, Steven M. Banks, and Sidney M. Wolfe
JAMA. 2008;299(19):2304-2312.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death
Lewis J. Levien, Richard E. Hodgson, and Michael F. M. James
JAMA. 2008;300(11):1295.
EXTRACT | FULL TEXT  

Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death
Peter E. Keipert, Christina Olofsson, and Robert M. Winslow
JAMA. 2008;300(11):1295-1296.
EXTRACT | FULL TEXT  

Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death
Roger J. Lewis and Norman Fost
JAMA. 2008;300(11):1296.
EXTRACT | FULL TEXT  

Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death
Aryeh Shander, Mazyar Javidroozi, and Gary Thompson
JAMA. 2008;300(11):1296-1297.
EXTRACT | FULL TEXT  

Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death
Angela Sauaia, Ernest E. Moore, and Anirban Banerjee
JAMA. 2008;300(11):1297.
EXTRACT | FULL TEXT  

Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death
Babak Sarani and Vicente Gracias
JAMA. 2008;300(11):1297-1298.
EXTRACT | FULL TEXT  

Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death—Reply
Dean Fergusson and Lauralyn McIntyre
JAMA. 2008;300(11):1299.
EXTRACT | FULL TEXT